However, RIPK4 may only play an oncogenic role in Wnt-dependent tumors, since RIPK4 knockdown do not affect Wnt3a-induced β-catenin accumulation in pancreatic, kidney, and breast cancer cells (Huang et al., 2013). Here, WNT3A is linked to breast cancer.